Share on LinkedInShare on LinkedIn

ARTICLE · 18 DECEMBER 2023

Managing ANDA Venue Issues As Del. And NJ Filings Rise

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

In 2023, pharmaceutical patent owners filed nearly 250 infringement complaints against generic drug manufacturers.

United StatesIntellectual Property

In 2023, pharmaceutical patent owners filed nearly 250 infringement complaints against generic drug manufacturers. More than 90% of those cases were filed in the Districts of Delaware or New Jersey.

Click here to continue reading . . .

Originally published Law360 on 1 December, 2023

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from